Friday, January 19, 2018

Broncho-Vaks

Description overdue on 09/15/2014

  • Latin name: Broncho-Vaxom
  • ATC code: L03A
  • Active substance: Lyophilisate bacterial lysates (Moraxella catarrhalis, Klebsiella ozaenae, Klebsiella pneumoniae, Streptococcus pyogenes, Staphylococcus aureus, Haemophilus influenzae, Streptococcus viridans, Streptococcus pneumoniae)
  • Manufacturer: OM PHARMA (Switzerland)
Photos of the drug
Tweet
  • Composition
  • Product form
  • Pharmacological action
  • Pharmacodynamics and pharmacokinetics
  • Indications
  • Contraindications
  • Side effects
  • Instructions for use (method and dosage)
  • Overdose
  • Cooperation
  • Terms of sale
  • Storage conditions
  • Shelf life
  • Reviews
  • Price, where to buy

 Broncho-Vaks

Composition

The capsules Broncho-Vaks (Broncho-Vaxom) contain lyophilizate bacterial lysates ( Moraxella catanhalis . Haemophilus influenzae . Staphylococcus aureus . Klebsiella pneumoniae . Streptococcus viridans . Klebsiella ozaenae . Streptococcus pneumoniae . Streptococcus pyogenes ).

In addition, they contain the following additional components: propyl, mannitol, magnesium stearate, indigotine, gelatin, anhydrous sodium glutamate, pregelatinized starch, titanium dioxide.

Product form

The drug is sold in capsules, which are contoured in containers (each containing 10 pcs.). They are kept in cardboard packets. In each of them one or 3-outline package.

Pharmacological action

The drug is an immunostimulatory agent.

Pharmacodynamics and pharmacokinetics

The drug has immunostimulating action. It promotes education immunoglobulins A, G, M Secreting airway mucosa. Furthermore, increases the number of T-lymphocyte .

When using the drug reduced the risk of infection during epidemics of respiratory tract infections, in addition, reduces the severity of the disease and the time of its stretch. Also significantly reduces the risk of bacterial complications acute respiratory infections .

Indications

For adults and children the drug is used for the following indicators:

  • the need to prevent re-infection of the respiratory tract;
  • the need to prevent deterioration bronchitis ;
  • acute respiratory tract infections .

Contraindications

The drug is contraindicated in:

  • children aged up to six months;
  • breast-feeding ;
  • first trimester pregnancy ;
  • hypersensitivity to its components.

Side effects

Unwanted side effects when using the drug observed very rarely, however, in rare cases possible nausea . cough . headache . dyspeptic symptoms . breathlessness .


In addition, there may be excessive fatigue and allergy . It was also reported cases of idiopathic urticaria . purpura . tachycardia . thrombocytopenia . arthralgia . But their connection with the course of Broncho-Vaksoma still not proven.

When side effects you should immediately contact the person who must decide whether to continue treatment.

Instructions for use (method and dosage)

Adult and children Broncho-Vaks administered orally.

Adults and children over 12 years old need to take one capsule funds Broncho-adult Vaks   every day before eating in the morning, until the symptoms disappear. The course lasts for at least 10 days. If you need another treatment, its duration should be determined by a specialist, based on the patient's condition.

When relapse prevention and maintenance therapy of daily administration of the scheme is the same. The course lasts for three cycles (each of them - 10 days), the interval between - 20 days.

The capsules can be opened and their contents mixed with water, fruit juice, milk and other beverages.

For children from 6 months to 12 years, experts appointed   Broncho-Vaks children . This drug should also take capsule daily in the morning before eating. It is recommended to calculate the course of 10 days. The contents of the capsule may be dissolved in water, juice, tea.

If necessary, the treatment can be repeated. Thus, for maximum effect, some patients are prescribed three course at intervals of 20 days in between.

Overdose

Information about the missing cases of overdose.

Cooperation

The interaction of the agent with other drugs has not been studied.

Terms of sale

The drug is sold by prescription.

Storage conditions

The optimum temperature - 15-25 ° C. The capsules should be kept in their original packaging.

Shelf life

The medicine should be stored no longer than 5 years.

Reviews

Broncho-Vaks received mostly positive reviews. Patients say that it helps to transfer disease in a milder form, and to avoid further complications. Many, however, requires not one but several courses of therapy. On the side-effects of the reviews are not reported.

Price Broncho-Vaksoma where to buy

Price Broncho-adult Vaks   10 packs in a carton box, an average of 400 rubles. Slightly lower cost medication to a child - about 360 rubles. Cost   Broncho-Vaks children   in Ukraine - about 117 hryvnia, and adult drug - 133 hryvnia.

Get the best price and buy

No comments:

Post a Comment